RETAIL NEWS

Ahold Delhaize CEO, chairman to retire following successful merger

BY Michael Johnsen

Ahold Delhaize on Thursday named Frans Muller to its CEO post, effective July 1, the day Ahold Delhaize’s current CEO, Dick Boer, plans to retire. In a separate announcement, Ahold Delhaize shared the retirement plans of its chairman as well.

“We thank Dick for his leadership and dedication throughout his 20-year career at Ahold Delhaize and Ahold. Dick’s accomplishments include the successful repositioning of Albert Heijn to market leadership, strategically building Ahold’s portfolio into brands with number one and two positions in the markets they serve and introducing digital, eCommerce and sustainability as integrated parts of the business,” Mats Jansson, current chairman of the international supermarket’s supervisory board, said. Jansson plans to retire April 11 (see below). “Dick has role-modelled the values of our ‘Better Together’ strategy, with his passion for retail, customers, associates and health. Under Dick’s leadership, two leading food retailers were brought together in an historic merger. With this merger now being substantially completed, Ahold Delhaize is now ready to move into its next phase.”

Muller has more than 20 years of experience in retail and has served as ceputy CEO and chief integration officer of Ahold Delhaize since July 24, 2016. He also led Delhaize America on an interim basis from October 2016 until January 2018. Prior to the merger between Ahold and Delhaize, Muller served as president and CEO of Delhaize Group from 2013. Before joining Delhaize Group, he served on the management board of German retailer Metro AG for seven years and was CEO of Metro Cash & Carry for five years.

“Together with Dick, Frans was instrumental in bringing together Ahold and Delhaize Group,” Jansson said. “During the past two years he has been driving the integration process in close collaboration with our great local brands and support offices. Frans brings a wealth of retail experience and a deep knowledge of our company, brands and U.S. and European markets, making him the natural choice as next CEO. Frans is committed to the brand-centric operating model which is key to our strategy and has the customer at its core. We are confident that Frans is the right person to lead the company into its next phase.“

“I’m honored to be given the opportunity to lead this company with such powerful brands, incredible talent and long-term growth potential – a combination that sets us apart globally,” Muller said. “Our success will be based upon delivering a great and seamless shopping experience for our customers, both in stores and online. Building on the solid foundations established under Dick’s leadership, we will continue to drive innovation and growth in stores and online as we execute our strategy and create value for all our stakeholders. My focus will be on delivering our promises to be a better place to shop, better place to work and better neighbor – every day.”

Boer will work closely with Muller to ensure a smooth transition on July 1, 2018 and he will remain available as advisor to the company until mid 2019.

In a separate announcement, Ahold Delhaize noted that Jansson is similarly retiring from the supervisory board next week following the company’s annual meeting April 11. Jan Hommen has been appointed chairman of the supervisory board as of the same date. Johnny Thijs and Patrick De Maeseneire will also step down after having indicated that they are unable to continue the membership of the supervisory board with their other commitments.

Jansson has been chairman of the supervisory board since the merger between Ahold and Delhaize Group in July 2016. Prior to that, he served as chairman of the board of directors of Delhaize Group.

“I leave Ahold Delhaize knowing that the company is well positioned for the future. I thank my colleagues in the supervisory board and especially Jan Hommen, with whom I have had the privilege of working closely, both before and after completing the merger of two leading food retail companies,” Jansson said. “It makes me proud to see what the teams at Ahold Delhaize have accomplished in two years, with the integration fully on track. For me this proves that we truly are ‘Better Together.’ I also thank Johnny Thijs and Patrick De Maeseneire for their valuable contributions during their terms at Ahold Delhaize and Delhaize Group.”

Jan Hommen has been vice chairman of the supervisory board since July 2016. Prior to the merger, Hommen served as chairman of Ahold’s supervisory board since 2013. Between 2003 and 2007, he was vice chairman of the supervisory board of Ahold and chairman of the audit committee. Hommen has an executive background as vice chairman of the board of management at Royal Philips Electronics and as CEO of ING Group and of KPMG the Netherlands.

The supervisory board has appointed Bill McEwan as vice chairman, succeeding Hommen.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
RETAIL NEWS

CNBC: Walmart could shake up health care more than Amazon

BY DSN STAFF

Walmart, more than Amazon, could make a real difference in health care.

That’s according to a report by CNBC, which said health experts agree that Walmart is the company to watch when it comes to disrupting health care.“Everyone in the country is talking about Amazon and its partners changing the landscape of self-insured, large employers,” Trevor Price, CEO of the health services firm Oxeon Partners, who closely follows Walmart, told CNBC. “But the company that has the biggest opportunity to change the landscape of health care, given all the Americans that walk through the door every week, is Walmart.”

Click here for more.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
RETAIL NEWS

Pharmasave to source medical cannabis from CanniMed

BY Michael Johnsen

Aurora Cannabis and CanniMed Therapeutics announced Wednesday that CanniMed has entered into a letter of intent to become a preferred supplier of medical cannabis to Pharmasave, member-governed cooperative of more than 650 independently owned community pharmacies across Canada.

“Canadians trust pharmacists to help guide them to the right information and products to treat their conditions,” Terry Booth, Aurora CEO, said. “And now Pharmasave joins two other national pharmacy chains in showing their trust in us to provide them with medical cannabis products and education. These supply agreements allow us strong penetration into what is likely to be a sizable portion of the medical cannabis market, and they highlight the strength of our organizations, the scale of our operations and the world-class operational standards that both Aurora and CanniMed practice. We’re proud to partner with Pharmasave and expand our ability to help Canadians in need find the relief they are seeking.”

Pharmasave recognized some time ago that pharmacists need to be prepared to fulfill their role as medication experts in the area of medical cannabis. As such, for more than a year, Pharmasave has been educating Pharmasave pharmacists to ensure they are prepared to support patients and physicians in medication management.

This includes how medical cannabis may affect other medications the patient may take, any health conditions they might have and insights on how to identify and address mental health and addiction concerns in patients. CanniMed has supported this commitment to understanding medical cannabis with product information, access to medical experts and updates on the latest research and clinical information available. In addition to supplying Pharmasave pharmacists with medical cannabis once permitted, CanniMed and Aurora will continue to provide pharmacists with education related to medical cannabis.

Subject to changes to regulations that would allow such distribution, CanniMed and Aurora will supply and distribute high-quality medical cannabis, produced at the companies’ GMP compliant and GMP certified facilities, through Pharmasave pharmacists.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?